Day: November 3, 2022

Market Activity

What Drove The Bone Biologics (BBLG) Stock Up 7% During After-Hour Trading?

Shares of Bone Biologics Corporation (Nasdaq: BBLG) were up 7.37% at $0.3758 at the time of our latest check in after-hours trading, which was followed by a CEO letter to the company’s stockholders. What did the CEO of BBLG disclose to the shareholders? The letter from Bone Biologics (BBLG) president and chief executive officer, Jeffrey Frelick, was recently distributed to the company’s shareholders. The highlights from BBLG’s letter: As it prepares to start its first-in-human pivotal trial in 2023, Bone Biologics briefed shareholders on its development work with NELL-1 over the last year and reviewed its anticipated milestones over the